Literature DB >> 28089586

Natural uranium impairs the differentiation and the resorbing function of osteoclasts.

Tatiana Gritsaenko1, Valérie Pierrefite-Carle1, Thomas Lorivel2, Véronique Breuil3, Georges F Carle1, Sabine Santucci-Darmanin4.   

Abstract

BACKGROUND: Uranium is a naturally occurring radionuclide ubiquitously present in the environment. The skeleton is the main site of uranium long-term accumulation. While it has been shown that natural uranium is able to perturb bone metabolism through its chemical toxicity, its impact on bone resorption by osteoclasts has been poorly explored. Here, we examined for the first time in vitro effects of natural uranium on osteoclasts.
METHODS: The effects of uranium on the RAW 264.7 monocyte/macrophage mouse cell line and primary murine osteoclastic cells were characterized by biochemical, molecular and functional analyses.
RESULTS: We observed a cytotoxicity effect of uranium on osteoclast precursors. Uranium concentrations in the μM range are able to inhibit osteoclast formation, mature osteoclast survival and mineral resorption but don't affect the expression of the osteoclast gene markers Nfatc1, Dc-stamp, Ctsk, Acp5, Atp6v0a3 or Atp6v0d2 in RAW 274.7 cells. Instead, we observed that uranium induces a dose-dependent accumulation of SQSTM1/p62 during osteoclastogenesis.
CONCLUSIONS: We show here that uranium impairs osteoclast formation and function in vitro. The decrease in available precursor cells, as well as the reduced viability of mature osteoclasts appears to account for these effects of uranium. The SQSTM1/p62 level increase observed in response to uranium exposure is of particular interest since this protein is a known regulator of osteoclast formation. A tempting hypothesis discussed herein is that SQSTM1/p62 dysregulation contributes to uranium effects on osteoclastogenesis. GENERAL SIGNIFICANCE: We describe cellular and molecular effects of uranium that potentially affect bone homeostasis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Osteoclast; Osteoclastogenesis; Resorption; SQSTM1/p62; Uranium

Mesh:

Substances:

Year:  2017        PMID: 28089586     DOI: 10.1016/j.bbagen.2017.01.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  3 in total

1.  Low doses of uranium and osteoclastic bone resorption: key reciprocal effects evidenced using new in vitro biomimetic models of bone matrix.

Authors:  Tatiana Gritsaenko; Valérie Pierrefite-Carle; Gaëlle Creff; Bastien Simoneau; Agnès Hagège; Delphine Farlay; Sophie Pagnotta; François Orange; Xavier Jaurand; Christophe Den Auwer; Georges F Carle; Sabine Santucci-Darmanin
Journal:  Arch Toxicol       Date:  2021-01-11       Impact factor: 5.153

2.  Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis.

Authors:  Tatiana Gritsaenko; Valérie Pierrefite-Carle; Gaëlle Creff; Claude Vidaud; Georges Carle; Sabine Santucci-Darmanin
Journal:  J Vis Exp       Date:  2018-01-30       Impact factor: 1.355

3.  METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.

Authors:  Di Li; Luhui Cai; Runsha Meng; Zhihui Feng; Qiong Xu
Journal:  Int J Mol Sci       Date:  2020-02-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.